$PZOO Signs Deal With Accuvape To Distribute Vaporizers And Related Products

CannabisKing will begin sales calls by the second week of July and expect to immediately garner orders.  This comprehensive product line is state of the art with the best in class support team at Accuvape for support of the end users.

ACCUVAPE is an electronics company that services the vaporizer industry as well as the growing cannabis market.  It provides industry related customized products and solutions such as: medium-specific vaporizers and electronics, inventory management, customer service and support, warranty servicing, private label services and parts/supplies.  ACCUVAPE believes in optimizing the customer and retailer experience through high-quality products, personal customer-service and easy policies and procedures.

CannabisKing was formed to be the marketing and sales agent representing non-controlled hemp products throughout the USA. Non-controlled hemp products are the items utilized by the industry that supports grow facilities, infusion companies and dispensaries. Through Pazoo’s two other subsidiary companies, strong relationships are already being forged with a large number of growers and other industry related enterprises. Accuvape is one of several products that CannabisKing will become a sales and distribution outlet for.

ACCUVAPE Founder and CEO Hilary Dulany states, “This is the partnership we’ve been waiting for.  Now we can bring the goods and services of ACCUVAPE to a wider range of businesses that need them most.”

Pazoo CEO David Cunic states, “We are thrilled to have this partnership with the Accuvape team.   Their team management, customized solutions, and customer service really separates them from their competitors.  Plus with their ability to go in the same regions as we are located, this product made complete sense to add to CannabisKing Distribution.”

ABOUT PAZOO Inc.

Pazoo, Inc., is a company focused on health, wellness and safety. Our focus is to provide best-in-class laboratory testing of cannabis and cannabinoids to protect consumers from impurities, contaminants and other irregularities. Through our wholly-owned subsidiary, Harris Lee, and our partnership with MA & Associates, Pazoo provides industry-leading laboratory testing of cannabis. Harris Lee’s and MA’s license agreements with Steep Hill Labs, Inc. allows the Pazoo subsidiaries to use Steep Hill’s top-rated testing protocols in select markets as we expand throughout the USA. Pazoo’s subsidiaries are currently licensed to test cannabis in Nevada, Oregon and Colorado, with other states to come. Additionally, Pazoo delivers a comprehensive array of health and wellness information on its website www.pazoo.com.

ABOUT STEEP HILL LABS Inc.

Founded in California in 2008, Steep Hill is a science and technology firm that has become the industry leader in cannabis testing and analytics. With owned and licensed labs in four U.S. states and plans to add labs in New Mexico, Oregon and possibly Jamaica in 2015, Steep Hill is the largest cannabis lab network in the world. The company pioneered the first medical cannabis potency and microbiological contaminants testing methodology for use in California – the first state to legalize medical cannabis. Steep Hill has since developed a variety of revolutionary cannabis testing products, including QuantaCann™, QuantaCann2™ and GenKit™. Steep Hillprovides expert consulting services to many states, countries and municipalities, and the company is developing proprietary genetic testing, mapping and trademark protection services for the industry as well.

Safe Harbor Statement:

This update includes forward-looking statements. These forward-looking statements generally can be identified by phrases such as Pazoo, Inc. or its management “believes,” “expects,” “anticipates,” “foresees,” “forecasts,” “estimates” or other words or phrases of similar import. Similarly, statements herein that describe the Company’s business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statement.